Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Published:2018-08 Issue:8 Volume:214 Page:1136-1141
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Bösmüller Hans,Pfefferle Vanessa,Bittar Zeid,Scheble Veit,Horger Marius,Sipos Bence^ORCID,Fend Falko

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference17 articles.

1. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells;Takahashi;Oncogene,1999

2. Vascular changes in hepatocellular carcinoma;Yang;Anat. Rec.,2008

3. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features;Hanna;Radiographics,2008

4. Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors (Review);Shimizu;Oncol. Rep.,2017

5. Diagnostic histopathology of hepatocellular carcinoma: a case-based review;Agni;Semin. Diagn. Pathol.,2017

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues—correlation with tumour aggressiveness;Frontiers in Cell and Developmental Biology;2024-07-03

2. Histopathological growth pattern and vessel co-option in intrahepatic cholangiocarcinoma;Medical Molecular Morphology;2024-07-03

3. Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery;Cancer Research;2024-06-11

4. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma;Scientific Reports;2024-03-04

5. Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppression;Pathology - Research and Practice;2023-12